HIV

Sessions

Wednesday, 23 November
13:20

Hepatitis C epidemiology and prevention

13:20 to 14:50
Knowledge market 3 (K3)
Stine Hoj

Prevention and control of infectious diseases among people who inject drugs: New evidence within the updated guidance from the ECDC and the EMCDDA

13:20 to 14:50
Networking zone 3 (N3)
Janelle Sandberg, Thomas Seyler
16:50

Treatment options for drug users in prisons in Central Asia and Germany

16:50 to 18:20
Networking zone 1 (N1)
Ingo Ilja Michels
Thursday, 24 November
09:00

Contemporary Issues

09:00 to 10:30
Central square 2 (C2)
Anne Line Bretteville-Jensen
13:20

Diversity, stigma, and vulnerability

13:20 to 14:50
Networking zone 4 (N4)
Dalia Ismail, Thomas Martinelli
Friday, 25 November
13:20

Substance use consequences and concerns

13:20 to 14:50
Networking zone 1 (N1)
Patrícia Pissarra

Presentations

e-poster

Demographic and socio-structural factors associated with non-fatal overdose among patients enrolled in the OPTIMA trial

Networking zone 1 (N1)
Hannah Crepeault

Wednesday, 23 November

13:20
Oral presentation

The effectiveness of low dead space syringes for reducing the risk of hepatitis C virus acquisition among people who inject drugs - findings from a national survey in UK

13:20 to 14:50
Knowledge market 3 (K3)
Peter Vickerman
Oral presentation

Global incidence of hepatitis C virus (HCV) and HIV infection among people who inject drugs: A systematic review and meta-analysis

13:20 to 14:50
Knowledge market 3 (K3)
Adelina Artenie
Oral presentation

Assessing the impact of COVID-19 and associated control measures on interventions to prevent drug-related harm among people who inject drugs in Scotland

13:20 to 14:50
Knowledge market 3 (K3)
Kirsten Trayner
Oral presentation

The Contribution of Unstable Housing to HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs Globally, Regionally, and at Country Level: A Modelling Study

13:20 to 14:50
Knowledge market 3 (K3)
Jack Stone
Oral presentation

1. Overview of the updated ECDC/EMCDDA guidance on the prevention and control of infectious diseases among people who inject drugs

13:20 to 14:50
Networking zone 3 (N3)
Anne Bergenstrom, Janelle Sandberg
Oral presentation

2. Effectiveness of drug treatment, needle and syringe programmes and drug consumption rooms in the prevention of blood-borne viruses among people who inject drugs – updated evidence from reviews of empirical and mathematical modelling studies

13:20 to 14:50
Networking zone 3 (N3)
Matthew Hickman
Oral presentation

3. Enhancing the HCV care cascade among people who inject drugs: a systematic review and considerations from an expert panel

13:20 to 14:50
Networking zone 3 (N3)
Ilonka Horváth
Discussion

Perspectives from government and civil society member(s) of the ECDC and EMCDDA expert panel on the key areas of intervention

13:20 to 14:50
Networking zone 3 (N3)
Janelle Sandberg, Anne Bergenstrom, Anna Tarján, Mat Southwell, Viktor Mravcik, Annette Verster, Slava Kushakov
16:50
Oral presentation

1. The role of social work in agency processes - empirical study using the example of people who use illicit substances with a history of imprisonment

16:50 to 18:20
Networking zone 1 (N1)
Daniela Jamin
Oral presentation

2. Social work with drug users in a probation system of Kyrgyzstan

16:50 to 18:20
Networking zone 1 (N1)
Estebes uulu Tynchtyk
Oral presentation

3. Health and social welfare in prisons in the Republic of Kazakhstan – women with HIV and the role of the social worker

16:50 to 18:20
Networking zone 1 (N1)
Dalida Mukasheva

Thursday, 24 November

09:00
Oral presentation

Addressing intimate partner abuse (IPA) perpetrated by heterosexual men in substance use treatment: the ADVANCE programme

09:00 to 10:30
Central square 2 (C2)
Gail Gilchrist
Oral presentation

ROSE: A peer-led intervention to support peer workers in overdose response settings in British Columbia

09:00 to 10:30
Central square 2 (C2)
Fred Cameron
Oral presentation

Stakeholders’ perceptions about their position and the dynamics between the stakeholders within Swedish drug policy field

09:00 to 10:30
Central square 2 (C2)
Tuulia Lerkkanen
Oral presentation

Switching from a criminalisation to a public health approach to injecting drug use in Eastern Europe and Central Asia: a modelling analysis of the costs and impact on HIV transmission

09:00 to 10:30
Central square 2 (C2)
Zoe Ward
13:20
Short communication

SHIFT + Parent Training - An Intervention for Mothers and Fathers Using Illicit Drugs'

13:20 to 14:50
Networking zone 4 (N4)
Diana Moesgen
Short communication

Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada

13:20 to 14:50
Networking zone 4 (N4)
Taylor Fleming
Short communication

Trends and factors associated with illicit drug use and HIV outcomes in South Africa: findings from multiple national population-based household surveys

13:20 to 14:50
Networking zone 4 (N4)
Kennedy Kipkoech
Short communication

Perceived Impact of Storytelling on Substance Use Self-Stigma

13:20 to 14:50
Networking zone 4 (N4)
Glenn Sterner
Short communication

Social attitudes towards drug users in the context of perceptions of other marginalised social groups, based on the NSAPH 2019 Survey

13:20 to 14:50
Networking zone 4 (N4)
Katalin Felvinczi
Short communication

Cannabis engagement in Riga, Latvia: Voices from impacted communities

13:20 to 14:50
Networking zone 4 (N4)
Kristiana Bebre
Short communication

Under-reporting of meth/amphetamine use in Australia following negative media coverage

13:20 to 14:50
Networking zone 4 (N4)
Daniel Stjepanovic
Short communication

Treatment of drug use disorders in Central Asia, China, and Germany – what is the state of the art?

13:20 to 14:50
Networking zone 4 (N4)
Ingo Ilja Michels

Friday, 25 November

13:20
e-poster

Alcohol Consumption during a Pandemic Lockdown Period and Change in Alcohol Consumption Related to Worries and Pandemic Measures

13:20 to 14:50
Networking zone 1 (N1)
Silvia Eiken Alpers
e-poster

Gender differences in HIV prevalence and all-cause mortality among people who inject drugs (PWID) in Estonia.

13:20 to 14:50
Networking zone 1 (N1)
Maris Salekesin
e-poster

Interaction between Alcohol Use Disorder, APOE4 and Cognitive Decline in patients undergoing an alcohol detoxification program

13:20 to 14:50
Networking zone 1 (N1)
Laura Orio
e-poster

Functional Connectivity in a Triple-Network Saliency Model is Associated with Real-Life Self-Control

13:20 to 14:50
Networking zone 1 (N1)
Klaus-Martin Krönke
e-poster

Lifestyle risk factors and racial and ethnic inequality in mortality: Decomposing differential exposure and vulnerability in the United States

13:20 to 14:50
Networking zone 1 (N1)
Klajdi Puka
e-poster

Acceptance-based, intersectional stigma coping intervention for people with HIV who inject drugs – an RCT in St. Petersburg, Russia

13:20 to 14:50
Networking zone 1 (N1)
Karsten Lunze
e-poster

Novel Psychoactive Substances (NPS) related health responses implemented in Europe through the lens of an intersectional risk environment approach

13:20 to 14:50
Networking zone 1 (N1)
Jessica Neicun